These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9686660)

  • 41. A Seven-year Study on the Effects of Intravenous Antibiotic Therapy on Infection of Ventriculoperitoneal Shunts in Children.
    Mostafavi SN; Khedmati M; Kelishadi R
    Pediatr Infect Dis J; 2020 Aug; 39(8):684-686. PubMed ID: 32235246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid shunt infections in children.
    Meirovitch J; Kitai-Cohen Y; Keren G; Fiendler G; Rubinstein E
    Pediatr Infect Dis J; 1987 Oct; 6(10):921-4. PubMed ID: 3696825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost savings associated with antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus.
    Parker SL; McGirt MJ; Murphy JA; Megerian JT; Stout M; Engelhart L
    World Neurosurg; 2015 Mar; 83(3):382-6. PubMed ID: 24933241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CSF shunt infections in children: experiences from a population-based study.
    Enger PØ; Svendsen F; Wester K
    Acta Neurochir (Wien); 2003 Apr; 145(4):243-8; discussion 248. PubMed ID: 12748883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal fluid shunt infections in children.
    Ronan A; Hogg GG; Klug GL
    Pediatr Infect Dis J; 1995 Sep; 14(9):782-6. PubMed ID: 8559628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience.
    Farber SH; Parker SL; Adogwa O; McGirt MJ; Rigamonti D
    Neurosurgery; 2011 Sep; 69(3):625-9; discussion 629. PubMed ID: 21499157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective randomized study of therapy in cerebrospinal fluid shunt infection.
    James HE; Walsh JW; Wilson HD; Connor JD; Bean JR; Tibbs PA
    Neurosurgery; 1980 Nov; 7(5):459-63. PubMed ID: 7003434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus.
    Govender ST; Nathoo N; van Dellen JR
    J Neurosurg; 2003 Nov; 99(5):831-9. PubMed ID: 14609161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rates of cerebrospinal fluid infection and the causative organisms following shunt procedures in Saudi Arabia. A retrospective study based on radiological findings.
    Al-Sharydah AM; Abu Melha YA; Al-Suhibani SS; Alojan AA; Al-Taei TH; Alfawaz II; AlShammari LT; Al-Jubran SA; Ammar AS
    Saudi Med J; 2020 Jun; 41(6):607-613. PubMed ID: 32518927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The treatment of infantile hydrocephalus: "differential-pressure" or "flow-control" valves. A pilot study.
    Jain H; Sgouros S; Walsh AR; Hockley AD
    Childs Nerv Syst; 2000 Apr; 16(4):242-6. PubMed ID: 10855523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of Hydromer-Coated and Antibiotic- Impregnated Shunt Systems in Reducing Early Shunt Infections in the Pediatric Population.
    Mayol M; Estronza S; Sosa IJ; Vigo JA; Pastrana EA
    P R Health Sci J; 2019 Dec; 38(4):244-247. PubMed ID: 31935310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus.
    Sciubba DM; Noggle JC; Carson BS; Jallo GI
    Pediatr Neurosurg; 2008; 44(2):91-6. PubMed ID: 18230921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.
    Test MR; Whitlock KB; Langley M; Riva-Cambrin J; Kestle JRW; Simon TD
    J Neurosurg Pediatr; 2019 Jul; 24(1):22-28. PubMed ID: 31051463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of ventricular shunt infections.
    O'Brien M; Parent A; Davis B
    Childs Brain; 1979; 5(3):304-9. PubMed ID: 456105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complications of ventriculoatrial and ventriculoperitoneal shunts in a new children's hospital.
    Ivan LP; Choo SH; Ventureyra EC
    Can J Surg; 1980 Nov; 23(6):566-8. PubMed ID: 7448660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections.
    Bafeltowska JJ; Buszman E; Mandat KM; Hawranek JK
    Surg Neurol; 2004 Aug; 62(2):142-50; discussion 150. PubMed ID: 15261509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children.
    Tuan TJ; Thorell EA; Hamblett NM; Kestle JR; Rosenfeld M; Simon TD
    Pediatr Infect Dis J; 2011 Sep; 30(9):731-5. PubMed ID: 21852762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of complicated shunt infections: a clinical report.
    James HE; Bradley JS
    J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What is the risk of infecting a cerebrospinal fluid-diverting shunt with percutaneous tapping?
    Spiegelman L; Asija R; Da Silva SL; Krieger MD; McComb JG
    J Neurosurg Pediatr; 2014 Oct; 14(4):336-9. PubMed ID: 25105511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.